查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1873979

成癮治療市場

Addictions Therapeutics Market
出版日期: | 出版商: The Insight Partners | 英文 150 Pages | 商品交期: 1-5個工作天內

價格
簡介目錄

2024年，成癮治療市場規模估計為91.4億美元，預計到2031年將達到144.9億美元，2031年至2031年的複合年成長率為7.3%。各種治療方法的不斷推出預計將成為成癮治療市場的重要趨勢。

成癮治療市場分析

各國領導人、監管機構和非政府組織正積極尋求創新方法，以提高公眾對日益嚴重的藥物成癮問題的認知並應對這一問題。例如，化學品濫用委員會參與了多項州級和國家級計劃，旨在提高公眾對藥物濫用、康復和預防的認知。

聯合國毒品和犯罪問題辦公室（毒品和犯罪問題辦公室）主導全球運動，旨在強調非法毒品，特別是青少年毒品問題，對社會帶來的重大挑戰。毒品和犯罪議題辦公室在全球各地進行各種宣傳活動，並鼓勵個人、私部門、非營利組織和成員國實施打擊毒品販運和濫用的宣傳方案。

此外，2023年8月，印度發起了一項旨在阻止青少年吸電子煙的運動。該運動旨在提出有效的解決方案，並尋求專家協助，以製定關於電子煙危害的有力宣傳訊息。它還試圖向公眾介紹印度和其他國家對電子煙的禁令，並解釋這些法規背後的原因。

此類旨在打擊藥物濫用和推廣各種成癮治療的宣傳活動和政府行動，可能會在預測期內推動市場成長。

成癮治療市場概覽

全球成癮治療市場按地區分類為北美、歐洲、亞太、中東和非洲以及南美和中美洲。北美佔據最大的市場佔有率，而亞太地區則是成長最快的地區。北美市場的成長主要歸功於新市場參與者的湧入、眾多產品的上市以及成癮人數的增加。此外，亞太地區的成癮治療市場也正經歷快速成長，其中中國、印度和日本是主要貢獻者，這得益於高濃度的毒品消費、成癮治療學名藥的廣泛研發以及本土企業的崛起。此外，跨國製藥公司對研發的投入也推動了市場成長。

戰略洞察

成癮治療市場的促進因素與機遇

加強組織間合作以促進市場成長

成癮治療市場中的許多機構正在建立合作關係，以促進市場成長。例如，2023年9月，Click Therapeutics與Indivior合作，共同開發和商業化處方數位療法，旨在治療物質使用障礙，首先從鴉片類藥物使用障礙（OUD）入手。此次合作將利用一款名為CT-102的行動應用程式，該程序旨在彌補OUD治療中的重大缺口，例如提供高品質、個人化的心理社會支持。

同樣，2023年1月，Pear Therapeutics擴大了與門診戒癮治療診所的合作。 Spero Health目前已能夠在五個州的99個地點使用Pear的reSET和reSET-O處方數位療法，而此前僅在肯塔基州的14家診所使用。因此，各機構之間日益增加的合作正在推動戒癮治療市場的成長。

合約機構對研發的需求日益成長——這是一個市場機會

近年來，受多種因素推動，製藥業的外包服務激增，這些因素包括止痛藥需求不斷成長、活性藥物成分（API）日益複雜以及降低研發成本的需要。大型製藥公司正透過外包研發活動來加速藥物開發，同時降低成本。

許多製藥公司，包括那些生產成癮治療藥物的公司，都依賴合約研究組織 (CRO) 來降低內部研發和生產相關的高昂固定成本。新分子實體 (NME) 研發的日益複雜化，催生了對專業能力的需求，而企業更傾向於外包而非內部管理這些能力。隨著藥物獲準數量的增加（FDA 在 2023 年批准了 55 種 NME），對強大的臨床開發和外包服務的需求也日益成長。多家生物技術公司正在利用 CRO 來增強其候選藥物管線。透過外包降低藥物生產成本，預計將為市場參與者帶來巨大的成長機會，使他們能夠最大限度地提高利潤率，並在不斷發展的成癮治療藥物市場中保持競爭力。

成癮治療市場細分分析

對成癮治療市場進行分析的關鍵細分市場包括治療類型、藥物類型、治療中心和配銷通路。

  • 依治療類型分類，成癮治療市場可分為尼古丁成癮治療、酒精成癮治療、鴉片類藥物成癮治療和其他物質成癮治療。 2023年，尼古丁成癮治療市佔率最大。
  • 依藥物類型分類，市場可分為伐尼克蘭、安非他酮、尼古丁替代療法產品、丁丙諾啡、納曲酮、雙硫崙和其他藥物。 2023年，伐尼克蘭佔據了最大的市場佔有率。
  • 就治療中心而言，市場分為門診治療中心、住宿治療中心和住院治療中心。 2023年，門診治療中心佔據市場主導地位。

成癮治療市場地理分析

成癮治療市場報告的地理範圍主要分為五個地區：北美、亞太、歐洲、中東和非洲以及南美/南美和中美洲。

北美是成癮治療領域的主要市場，其中美國市場佔有率最大，其次是加拿大。北美市場的成長特點是新市場參與者的湧入、各種產品的推出以及藥物成癮人數的不斷增加。美國市場參與者正在籌集資金用於成癮治療。例如，2023年7月，致力於透過數位科技創新成癮治療的Affect Therapeutics公司宣布，已完成由專注於科技生物領域的投資公司ARTIS Ventures領投的A輪融資，金額達1,600萬美元。這筆資金將用於拓展公司在全美範圍內的項目，並透過技術改進提升Affect應用程式的效能。

成癮治療市場報告範圍

成癮治療市場最新動態及新聞

成癮治療市場評估是透過收集定性和定量資料進行的，數據來源包括一手和二手研究，例如重要的企業出版物、協會資料和資料庫。以下是成癮治療市場的一些最新發展：

  • 2023年1月，Hikma Pharmaceuticals PLC推出了預充式注射器（PFS）形式的鹽酸納洛酮注射（USP，2mg/2mL）。該藥物用於緊急治療已知或疑似鴉片類藥物過量，是該公司推出的第三款PFS產品。該注射液目前已在美國上市。 （資料來源：Hikma Pharmaceuticals PLC，2023）
  • 2022年1月，輝瑞與瑞典新創公司Alex Therapeutics合作，進軍數位療法市場。 Alex Therapeutics的AI驅動平台將認知行為療法（CBT）和接受與承諾療法（ACT）與人工智慧相結合，以實現個人化治療。雙方的合作初期專注於開發用於治療尼古丁成癮的數位療法，首先在德國市場展開。 （圖片來源：輝瑞，2022）

成癮治療市場報告的覆蓋範圍和交付成果

這份題為《成癮治療市場規模及預測（2022-2030）》的報告對市場進行了全面分析，涵蓋以下領域：

  • 涵蓋範圍內所有關鍵細分市場的全球、區域和國家層面的市場規模和預測
  • 市場動態，例如促進因素、限制因素和關鍵機會
  • 未來主要趨勢
  • 詳細的PEST/波特五力模型與SWOT分析
  • 全球及區域市場分析，涵蓋關鍵趨勢、主要參與者、法規及最新發展
  • 產業格局和競爭分析，包括市場集中度、熱力圖分析、主要參與者和最新發展動態
  • 公司詳細概況

目錄

第1章：引言

第2章：成癮治療市場及主要結論

第3章：研究方法

  • 覆蓋範圍
  • 二手研究
  • 初步研究

第4章：成癮治療市場及市場格局

  • 概述
  • PEST分析
    • 北美和PEST分析
    • 歐洲和PEST分析
    • 亞太地區及PEST分析
    • 中東和非洲 (MEA) 及 PEST 分析
    • 南美洲和中美洲（SCAM）及PEST分析

第5章：成癮治療市場及主要市場動態

  • 市場促進因素
    • 一般人群中成癮問題日益嚴重
    • 進行宣傳活動
  • 市場約束
    • 藥物研發成本不斷攀升
  • 市場機遇
    • 合約組織對研發的需求日益成長
  • 未來趨勢
    • 持續推出治療藥物
  • 影響分析

第6章：成癮治療市場及全球分析

  • 全球成癮治療市場收入預測與分析
  • 全球成癮治療市場（按地域分類）－預測與分析
  • 關鍵參與者的市場定位

第7章：成癮治療市場與治療類型

  • 概述
  • 成癮治療市場佔有率、治療類型，2024 年及 2031 年（%）
  • 尼古丁成癮治療
    • 概述
      • 尼古丁成癮治療：成癮治療市場及收入預測（至2031年）
  • 酒精成癮治療
    • 概述
      • 酒精成癮治療：成癮治療市場及收入預測（至2031年）
  • 鴉片類藥物成癮治療
    • 概述
      • 鴉片類藥物成癮治療：成癮治療市場及收入預測（至2031年）
  • 其他物質成癮治療
    • 概述
    • 其他物質成癮治療：成癮治療市場及收入預測（至2031年）

第8章：成癮治療市場與藥物類型

  • 概述
  • 成癮治療藥物市場佔有率（按藥物類型分類），2024 年和 2031 年（%）
  • 伐尼克蘭
    • 概述
      • 伐尼克蘭：成癮治療市場及收入預測（至2031年）
  • 安非他酮
    • 概述
      • 安非他酮：成癮治療市場及收入預測（至2031年）
  • 尼古丁替代產品
    • 概述
      • 尼古丁替代療法產品：成癮治療市場及收入預測（至2031年）
  • 丁丙諾啡
    • 概述
      • 丁丙諾啡：成癮治療市場及收入預測（至2031年）
  • 納曲酮
    • 概述
      • 納曲酮：成癮治療市場及收入預測（至2031年）
  • 雙硫崙
    • 概述
      • 雙硫崙：成癮治療市場及收入預測（至2031年）
  • 其他
    • 概述
      • 其他：成癮治療市場及收入預測（至2031年）

第9章：成癮治療市集與治療中心

  • 概述
  • 成癮治療市場佔有率，治療中心，2024 年和 2031 年（%）
  • 門診治療中心
    • 概述
      • 門診治療中心：成癮治療市場及收入預測（至2031年）
  • 住宅治療中心
    • 概述
      • 住宅治療中心：成癮治療市場及收入預測（至2031年）
  • 住院治療中心
    • 概述
      • 住院治療中心：成癮治療市場及收入預測（至2031年）

第10章：成癮治療市場配銷通路

  • 概述
  • 成癮治療市場佔有率、配銷通路，2024 年及 2031 年（%）
  • 醫院藥房
    • 概述
      • 醫院藥局：成癮治療市場及收入預測（至2031年）
  • 醫療用品商店
    • 概述
      • 醫療用品商店：成癮治療市場及收入預測（至2031年）
  • 其他
    • 概述
      • 其他：成癮治療市場及收入預測（至2031年）

第11章：成癮治療市場分析及至2031年預測與地理分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 亞太其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 中東和非洲其他地區
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地區

第12章：新冠疫情對全球成癮治療市場的影響

  • 北美洲
  • 歐洲
  • 亞太
  • 世界其他地區

第13章：成癮治療市場及產業概況

  • 概述
  • 市場中各公司採取的成長策略（%）
  • 有機發展
    • 概述
  • 無機物發展
    • 概述

第14章：公司簡介

  • Indivior PLC
  • Pfizer Inc.
  • GlaxoSmithKline plc.
  • Bausch Health Companies Inc.
  • Cipla Inc.
  • Orexo AB
  • Purdue Pharma L.P.
  • Alvogen
  • Camurus AB
  • Hikma Pharmaceuticals PLC

第15章：附錄

簡介目錄
Product Code: TIPRE00015265

The size of the Addictions Therapeutics Market was estimated at US$ 9.14 billion in 2024 and is projected to reach US$ 14.49 billion by 2031, reflecting a CAGR of 7.3% through 2031 - 2031. The ongoing introduction of various therapeutics is anticipated to be a significant trend in the Addictions Therapeutics Market.

Analysis of the Addictions Therapeutics Market

Leaders, regulatory bodies, and NGOs are actively seeking innovative methods to raise awareness and combat the escalating issue of substance addiction. For example, the Council on Chemical Abuse engages in numerous state and national initiatives aimed at increasing awareness about substance misuse, recovery, and prevention.

The United Nations Office on Drugs and Crime (UNODC) spearheads a global campaign to highlight the significant societal challenges posed by illicit drugs, particularly among youth. The UNODC conducts various awareness initiatives worldwide and encourages individuals, the private sector, non-profit organizations, and member states to implement outreach programs against drug trafficking and abuse.

Additionally, in August 2023, a campaign was initiated in India to deter adolescents from vaping. This campaign aimed to propose effective solutions and enlisted expert assistance to develop impactful messaging about the harmful effects of vaping. It also sought to inform the public about the vaping ban in India and other nations, explaining the rationale behind such regulations.

Such awareness initiatives and governmental actions aimed at combating drug abuse and promoting treatments for various addictions are likely to drive market growth during the forecast period.

Overview of the Addictions Therapeutics Market

The global addictions therapeutics market is categorized by region into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. North America commands the largest market share, while the Asia Pacific region is the fastest-growing area. The growth in North America is primarily attributed to the entry of new market players, numerous product launches, and an increasing number of individuals with one or more substance addictions. Furthermore, the Asia Pacific region is experiencing rapid growth in addiction therapeutics, with China, India, and Japan being key contributors due to high narcotic consumption, extensive development of generic drugs for addiction treatment, and the rise of local companies. Additionally, investments in research and development (R&D) by multinational pharmaceutical firms are also propelling market growth.

Strategic Insights

Drivers and Opportunities in the Addictions Therapeutics Market

Increasing Collaborations Among Organizations to Boost Market Growth

Numerous organizations within the addictions therapeutics market are forming partnerships that enhance market growth. For instance, in September 2023, Click Therapeutics partnered with Indivior to develop and commercialize prescription digital therapeutics aimed at treating substance use disorders, beginning with Opioid Use Disorder (OUD). This collaboration will utilize a mobile application named CT-102, designed to fill significant gaps in OUD treatment, such as providing access to high-quality, personalized psychosocial support.

Similarly, in January 2023, Pear Therapeutics expanded its collaboration with outpatient addiction treatment clinics. Spero Health is now able to utilize Pear's reSET and reSET-O prescription digital therapeutics across 99 locations in five states, up from just 14 clinics in Kentucky. Thus, the increasing partnerships among organizations are driving the growth of the addictions therapeutics market.

Growing Demand for R&D from Contract Organizations - A Market Opportunity

In recent years, the pharmaceutical sector has seen a surge in outsourcing services, driven by factors such as the rising demand for pain medications, increased complexity of active pharmaceutical ingredients (APIs), and the need to lower development costs. Major pharmaceutical companies are outsourcing R&D activities to accelerate drug development while also reducing their costs.

Many pharmaceutical companies, including those producing addiction therapeutics, depend on contract research organizations (CROs) to lower the high fixed costs associated with in-house development and manufacturing. The growing complexity in developing new molecular entities (NMEs) has created a demand for specialized capabilities that companies prefer to outsource rather than manage internally. With an increase in drug approvals (the FDA approved 55 NMEs in 2023), there is a heightened demand for robust clinical development and outsourcing. Various biotechnology firms are leveraging CROs to enhance their drug candidate pipelines. The cost reductions in drug manufacturing through outsourcing are expected to present significant growth opportunities for market players, enabling them to maximize profit margins and remain competitive in the evolving addictions therapeutics market.

Segmentation Analysis of the Addictions Therapeutics Market

Key segments contributing to the analysis of the addictions therapeutics market include treatment type, drug type, treatment center, and distribution channel.

  • By treatment type, the addictions therapeutics market is divided into nicotine addiction treatment, alcohol addiction treatment, opioid addiction treatment, and treatment for other substance addictions. The nicotine addiction treatment segment held the largest market share in 2023.
  • In terms of drug type, the market is categorized into varenicline, bupropion, nicotine replacement products, buprenorphine, naltrexone, disulfiram, and others. The varenicline segment accounted for the largest market share in 2023.
  • Regarding treatment centers, the market is segmented into outpatient treatment centers, residential treatment centers, and inpatient treatment centers. The outpatient treatment center segment led the market in 2023.

Geographical Analysis of the Addictions Therapeutics Market

The geographical scope of the addictions therapeutics market report is primarily divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South America/South & Central America.

North America is the leading market for addiction therapeutics, with the US holding the largest market share, followed by Canada. The growth in North America is characterized by the entry of new market players, various product launches, and an increasing number of individuals with substance addictions. Market participants in the US are raising funds for addiction treatment. For example, in July 2023, Affect Therapeutics, a company innovating addiction treatment through digital technology, announced it raised US$16 million in a Series A funding round led by ARTIS Ventures, a TechBio-focused investment firm. The funds will be utilized to expand the company's programs nationally and enhance the Affect app through engineering advancements.

Scope of the Addictions Therapeutics Market Report

Recent Developments and News in the Addictions Therapeutics Market

The addictions therapeutics market is assessed by collecting both qualitative and quantitative data through primary and secondary research, which includes significant corporate publications, association data, and databases. Below are some recent developments in the addictions therapeutics market:

  • In January 2023, Hikma Pharmaceuticals PLC launched Naloxone Hydrochloride Injection, USP, 2mg/2mL, in prefilled syringe (PFS) form. This medication is intended for the emergency treatment of known or suspected opioid overdoses and is the third PFS product introduced. The injection is currently available in the US. (Source: Hikma Pharmaceuticals PLC, 2023)
  • In January 2022, Pfizer partnered with Swedish start-up Alex Therapeutics to enter the digital therapeutics market. Alex Therapeutics' AI-driven platform combines cognitive behavioral therapy (CBT) and Acceptance and Commitment Therapy (ACT) with AI to tailor care. Their partnership initially focuses on developing digital therapeutics for nicotine addiction treatment, starting in the German market. (Source: Pfizer, 2022)

Coverage and Deliverables of the Addictions Therapeutics Market Report

The report titled "Addictions Therapeutics Market Size and Forecast (2022-2030)" provides a comprehensive analysis of the market, covering the following areas:

  • Market size and forecast at global, regional, and country levels for all key market segments included in the scope
  • Market dynamics such as drivers, restraints, and key opportunities
  • Key future trends
  • Detailed PEST/Porter's Five Forces and SWOT analysis
  • Global and regional market analysis covering key trends, major players, regulations, and recent developments
  • Industry landscape and competition analysis including market concentration, heat map analysis, prominent players, and recent developments
  • Detailed company profiles

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Addictions Therapeutics Market and By Treatment Type
    • 1.3.2 Addictions Therapeutics Market and By Drug Type
    • 1.3.3 Addictions Therapeutics Market and By Treatment Center
    • 1.3.4 Addictions Therapeutics Market and By Distribution Channel
    • 1.3.5 Global Addictions Therapeutics Market and By Geography

2. Addictions Therapeutics Market and Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Addiction Therapeutics Market and Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America and PEST Analysis
    • 4.2.2 Europe and PEST Analysis
    • 4.2.3 Asia-Pacific and PEST Analysis
    • 4.2.4 Middle East and Africa (MEA)and PEST Analysis
    • 4.2.5 South and Central America (SCAM) and PEST Analysis

5. Addiction Therapeutics Market and Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Rising Addiction Among General Populace
    • 5.1.2 Conduction of Awareness Campaigns
  • 5.2 Market Restraint
    • 5.2.1 Steeping Costs of Drug Development
  • 5.3 Market Opportunity
    • 5.3.1 Rising Demand for R and D from Contract Organizations
  • 5.4 Future Trend
    • 5.4.1 Consistent Launch of Therapeutics
  • 5.5 Impact Analysis

6. Addiction Therapeutics Market and Global Analysis

  • 6.1 Global Addictions Therapeutics Marker Revenue Forecast and Analysis
  • 6.2 Global Addictions Therapeutics Market, By Geography - Forecast And Analysis
  • 6.3 Market Positioning of Key Players

7. Addictions Therapeutics Marketand Treatment Type

  • 7.1 Overview
  • 7.2 Addictions Therapeutics Market Share, Treatment Type, 2024 and 2031 (%)
  • 7.3 Nicotine Addiction Treatment
    • 7.3.1 Overview
      • 7.3.1.1 Nicotine Addiction Treatment: Addictions Therapeutics Marketand Revenue and Forecast to 2031 (US$ million)
  • 7.4 Alcohol Addiction Treatment
    • 7.4.1 Overview
      • 7.4.1.1 Alcohol Addiction Treatment: Addictions Therapeutics Marketand Revenue and Forecast to 2031 (US$ million)
  • 7.5 Opioid Addiction Treatment
    • 7.5.1 Overview
      • 7.5.1.1 Opioid Addiction Treatment: Addictions Therapeutics Marketand Revenue and Forecast to 2031 (US$ million)
  • 7.6 Other Substance Addiction Treatment
    • 7.6.1 Overview
    • 7.6.2 Other Substance Addiction Treatment: Addictions Therapeutics Marketand Revenue and Forecast to 2031 (US$ million)

8. Addictions Therapeutics Marketand Drug Type

  • 8.1 Overview
  • 8.2 Addictions Therapeutics Market Share, Drug Type, 2024 and 2031 (%)
  • 8.3 Varenicline
    • 8.3.1 Overview
      • 8.3.1.1 Varenicline: Addictions Therapeutics Marketand Revenue and Forecast to 2031 (US$ million)
  • 8.4 Bupropion
    • 8.4.1 Overview
      • 8.4.1.1 Bupropion: Addictions Therapeutics Marketand Revenue and Forecast to 2031 (US$ million)
  • 8.5 Nicotine Replacement Products
    • 8.5.1 Overview
      • 8.5.1.1 Nicotine Replacement Products: Addictions Therapeutics Marketand Revenue and Forecast to 2031 (US$ million)
  • 8.6 Buprenorphine
    • 8.6.1 Overview
      • 8.6.1.1 Buprenorphine: Addictions Therapeutics Marketand Revenue and Forecast to 2031 (US$ million)
  • 8.7 Naltrexone
    • 8.7.1 Overview
      • 8.7.1.1 Naltrexone: Addictions Therapeutics Marketand Revenue and Forecast to 2031 (US$ million)
  • 8.8 Disulfiram
    • 8.8.1 Overview
      • 8.8.1.1 Disulfiram: Addictions Therapeutics Marketand Revenue and Forecast to 2031 (US$ million)
  • 8.9 Others
    • 8.9.1 Overview
      • 8.9.1.1 Others: Addictions Therapeutics Marketand Revenue and Forecast to 2031 (US$ million)

9. Addictions Therapeutics Marketand Treatment Center

  • 9.1 Overview
  • 9.2 Addictions Therapeutics Market Share, Treatment Center, 2024 and 2031 (%)
  • 9.3 Outpatient Treatment Center
    • 9.3.1 Overview
      • 9.3.1.1 Outpatient Treatment Center: Addictions Therapeutics Marketand Revenue and Forecast to 2031 (US$ million)
  • 9.4 Residential Treatment Center
    • 9.4.1 Overview
      • 9.4.1.1 Residential Treatment Center: Addictions Therapeutics Marketand Revenue and Forecast to 2031 (US$ million)
  • 9.5 Inpatient Treatment Center
    • 9.5.1 Overview
      • 9.5.1.1 Inpatient Treatment Center: Addictions Therapeutics Marketand Revenue and Forecast to 2031 (US$ million)

10. Addictions Therapeutics Marketand Distribution Channel

  • 10.1 Overview
  • 10.2 Addictions Therapeutics Market Share, Distribution Channel, 2024 and 2031 (%)
  • 10.3 Hospital Pharmacies
    • 10.3.1 Overview
      • 10.3.1.1 Hospital Pharmacies: Addictions Therapeutics Marketand Revenue and Forecast to 2031 (US$ million)
  • 10.4 Medical Stores
    • 10.4.1 Overview
      • 10.4.1.1 Medical Stores: Addictions Therapeutics Marketand Revenue and Forecast to 2031 (US$ million)
  • 10.5 Others
    • 10.5.1 Overview
      • 10.5.1.1 Others: Addictions Therapeutics Marketand Revenue and Forecast to 2031 (US$ million)

11. Addiction Therapeutics Market Analysis and Forecasts To 2031 and Geographical Analysis

  • 11.1 North America: Addiction Therapeutics Market
    • 11.1.1 Overview
    • 11.1.2 North America: Addiction Therapeutics Market, - Revenue and Forecast to 2031 (USD Million)
    • 11.1.3 North America: Addiction Therapeutics Market, by Treatment Typeand Revenue and Forecast to 2031 (USD Million)
    • 11.1.4 North America: Addiction Therapeutics Market, by Drug Type and Revenue and Forecast to 2031 (USD Million)
    • 11.1.5 North America: Addiction Therapeutics Market, by Treatment Center and Revenue and Forecast to 2031 (USD Million)
    • 11.1.6 North America: Addiction Therapeutics Market, by Distribution Channel and Revenue and Forecast to 2031 (USD Million)
    • 11.1.7 North America: Addiction Therapeutics Market, by Country, 2024 and 2031 (%)
    • 11.1.8 US: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
      • 11.1.8.1 US: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
      • 11.1.8.2 US: Addiction Therapeutics Market, by Treatment Type and Revenue and Forecast to 2031 (USD Million)
      • 11.1.8.3 US: Addiction Therapeutics Market, by Drug Type and Revenue and Forecast to 2031 (USD Million)
      • 11.1.8.4 US: Addiction Therapeutics Market, by Treatment Center and Revenue and Forecast to 2031 (USD Million)
      • 11.1.8.5 US: Addiction Therapeutics Market, by Distribution Channel and Revenue and Forecast to 2031 (USD Million)
    • 11.1.9 Canada: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
      • 11.1.9.1 Canada: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
      • 11.1.9.2 Canada: Addiction Therapeutics Market, by Treatment Type and Revenue and Forecast to 2031 (USD Million)
      • 11.1.9.3 Canada: Addiction Therapeutics Market, by Drug Type and Revenue and Forecast to 2031 (USD Million)
      • 11.1.9.4 Canada: Addiction Therapeutics Market, by Treatment Center and Revenue and Forecast to 2031 (USD Million)
      • 11.1.9.5 Canada: Addiction Therapeutics Market, by Distribution Channel and Revenue and Forecast to 2031 (USD Million)
    • 11.1.10 Mexico: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
      • 11.1.10.1 Mexico: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
      • 11.1.10.2 Mexico: Addiction Therapeutics Market, by Treatment Type and Revenue and Forecast to 2031 (USD Million)
      • 11.1.10.3 Mexico: Addiction Therapeutics Market, by Drug Type and Revenue and Forecast to 2031 (USD Million)
      • 11.1.10.4 Mexico: Addiction Therapeutics Market, by Treatment Center and Revenue and Forecast to 2031 (USD Million)
      • 11.1.10.5 Mexico: Addiction Therapeutics Market, by Distribution Channel and Revenue and Forecast to 2031 (USD Million)
  • 11.2 Europe: Addiction Therapeutics Market
    • 11.2.1 Overview
    • 11.2.2 Europe: Addiction Therapeutics Market, - Revenue and Forecast to 2031 (USD Million)
    • 11.2.3 Europe: Addiction Therapeutics Market, by Treatment Type and Revenue and Forecast to 2031 (USD Million)
    • 11.2.4 Europe: Addiction Therapeutics Market, by Drug Type and Revenue and Forecast to 2031 (USD Million)
      • 11.2.4.1 Europe: Addiction Therapeutics Market, by Treatment Center and Revenue and Forecast to 2031 (USD Million)
    • 11.2.5 Europe: Addiction Therapeutics Market, by Distribution Channel and Revenue and Forecast to 2031 (USD Million)
    • 11.2.6 Europe: Addiction Therapeutics Market, by Country, 2024 and 2031 (%)
    • 11.2.7 Germany: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
      • 11.2.7.1 Germany: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
      • 11.2.7.2 Germany: Addiction Therapeutics Market, by Treatment Type and Revenue and Forecast to 2031 (USD Million)
      • 11.2.7.3 Germany: Addiction Therapeutics Market, by Drug Type and Revenue and Forecast to 2031 (USD Million)
      • 11.2.7.4 Germany: Addiction Therapeutics Market, by Treatment Center and Revenue and Forecast to 2031 (USD Million)
      • 11.2.7.5 Germany: Addiction Therapeutics Market, by Distribution Channel and Revenue and Forecast to 2031 (USD Million)
    • 11.2.8 UK: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
      • 11.2.8.1 UK: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
      • 11.2.8.2 UK: Addiction Therapeutics Market, by Treatment Type and Revenue and Forecast to 2031 (USD Million)
      • 11.2.8.3 UK: Addiction Therapeutics Market, by Drug Type and Revenue and Forecast to 2031 (USD Million)
      • 11.2.8.4 UK: Addiction Therapeutics Market, by Treatment Center and Revenue and Forecast to 2031 (USD Million)
      • 11.2.8.5 UK: Addiction Therapeutics Market, by Distribution Channel and Revenue and Forecast to 2031 (USD Million)
    • 11.2.9 France: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
      • 11.2.9.1 France: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
      • 11.2.9.2 France: Addiction Therapeutics Market, by Treatment Type and Revenue and Forecast to 2031 (USD Million)
      • 11.2.9.3 France: Addiction Therapeutics Market, by Drug Type and Revenue and Forecast to 2031 (USD Million)
      • 11.2.9.4 France: Addiction Therapeutics Market, by Treatment Center and Revenue and Forecast to 2031 (USD Million)
      • 11.2.9.5 France: Addiction Therapeutics Market, by Distribution Channel and Revenue and Forecast to 2031 (USD Million)
    • 11.2.10 Italy: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
      • 11.2.10.1 Italy: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
      • 11.2.10.2 Italy: Addiction Therapeutics Market, by Treatment Type and Revenue and Forecast to 2031 (USD Million)
      • 11.2.10.3 Italy: Addiction Therapeutics Market, by Drug Type and Revenue and Forecast to 2031 (USD Million)
      • 11.2.10.4 Italy: Addiction Therapeutics Market, by Treatment Center and Revenue and Forecast to 2031 (USD Million)
      • 11.2.10.5 Italy: Addiction Therapeutics Market, by Distribution Channel and Revenue and Forecast to 2031 (USD Million)
    • 11.2.11 Spain: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
      • 11.2.11.1 Spain: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
      • 11.2.11.2 Spain: Addiction Therapeutics Market, by Treatment Type and Revenue and Forecast to 2031 (USD Million)
      • 11.2.11.3 Spain: Addiction Therapeutics Market, by Drug Type and Revenue and Forecast to 2031 (USD Million)
      • 11.2.11.4 Spain: Addiction Therapeutics Market, by Treatment Center and Revenue and Forecast to 2031 (USD Million)
      • 11.2.11.5 Spain: Addiction Therapeutics Market, by Distribution Channel and Revenue and Forecast to 2031 (USD Million)
    • 11.2.12 Rest of Europe: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
      • 11.2.12.1 Rest of Europe: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
      • 11.2.12.2 Rest of Europe: Addiction Therapeutics Market, by Treatment Type and Revenue and Forecast to 2031 (USD Million)
      • 11.2.12.3 Rest of Europe: Addiction Therapeutics Market, by Drug Type and Revenue and Forecast to 2031 (USD Million)
      • 11.2.12.4 Rest of Europe: Addiction Therapeutics Market, by Treatment Center and Revenue and Forecast to 2031 (USD Million)
      • 11.2.12.5 Rest of Europe: Addiction Therapeutics Market, by Distribution Channel and Revenue and Forecast to 2031 (USD Million)
  • 11.3 Asia Pacific: Addiction Therapeutics Market
    • 11.3.1 Overview
    • 11.3.2 Asia Pacific: Addiction Therapeutics Market - Revenue and Forecast to 2031 (USD Million)
    • 11.3.3 Asia Pacific Addiction Therapeutics Market, by Treatment Typeand Revenue and Forecast to 2031 (USD Million)
    • 11.3.4 Asia Pacific Addiction Therapeutics Market, by Drug Typeand Revenue and Forecast to 2031 (USD Million)
    • 11.3.5 Asia Pacific Addiction Therapeutics Market, by Treatment Center and Revenue and Forecast to 2031 (USD Million)
    • 11.3.6 Asia-Pacific: Addiction Therapeutics Market, by Distribution Channel and Revenue and Forecast to 2031 (USD Million)
    • 11.3.7 Asia Pacific: Addiction Therapeutics Market, by Country, 2024 and 2031 (%)
    • 11.3.8 China: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
      • 11.3.8.1 China: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
      • 11.3.8.2 China Addiction Therapeutics Market, by Treatment Typeand Revenue and Forecast to 2031 (USD Million)
      • 11.3.8.3 China Addiction Therapeutics Market, by Drug Typeand Revenue and Forecast to 2031 (USD Million)
      • 11.3.8.4 China Addiction Therapeutics Market, by Treatment Center and Revenue and Forecast to 2031(USD Million)
      • 11.3.8.5 China: Addiction Therapeutics Market, by Distribution Channel and Revenue and Forecast to 2031 (USD Million)
    • 11.3.9 Japan: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
      • 11.3.9.1 Japan: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
      • 11.3.9.2 Japan Addiction Therapeutics Market, by Treatment Typeand Revenue and Forecast to 2031 (USD Million)
      • 11.3.9.3 Japan Addiction Therapeutics Market, by Drug Typeand Revenue and Forecast to 2031 (USD Million)
      • 11.3.9.4 Japan Addiction Therapeutics Market, by Treatment Center and Revenue and Forecast to 2031(USD Million)
      • 11.3.9.5 Japan: Addiction Therapeutics Market, by Distribution Channel and Revenue and Forecast to 2031 (USD Million)
    • 11.3.10 India: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
      • 11.3.10.1 India: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
      • 11.3.10.2 India Addiction Therapeutics Market, by Treatment Typeand Revenue and Forecast to 2031 (USD Million)
      • 11.3.10.3 India Addiction Therapeutics Market, by Drug Typeand Revenue and Forecast to 2031 (USD Million)
      • 11.3.10.4 India Addiction Therapeutics Market, by Treatment Center and Revenue and Forecast to 2031(USD Million)
      • 11.3.10.5 India: Addiction Therapeutics Market, by Distribution Channel and Revenue and Forecast to 2031 (USD Million)
    • 11.3.11 South Korea: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
      • 11.3.11.1 South Korea: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
      • 11.3.11.2 South Korea Addiction Therapeutics Market, by Treatment Typeand Revenue and Forecast to 2031 (USD Million)
      • 11.3.11.3 South Korea Addiction Therapeutics Market, by Drug Typeand Revenue and Forecast to 2031 (USD Million)
      • 11.3.11.4 South Korea Addiction Therapeutics Market, by Treatment Center and Revenue and Forecast to 2031(USD Million)
      • 11.3.11.5 South Korea: Addiction Therapeutics Market, by Distribution Channel and Revenue and Forecast to 2031 (USD Million)
    • 11.3.12 Australia: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
      • 11.3.12.1 Australia: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
      • 11.3.12.2 Australia Addiction Therapeutics Market, by Treatment Typeand Revenue and Forecast to 2031 (USD Million)
      • 11.3.12.3 Australia Addiction Therapeutics Market, by Drug Typeand Revenue and Forecast to 2031 (USD Million)
    • 11.3.13 Australia Addiction Therapeutics Market, by Treatment Center and Revenue and Forecast to 2031 (USD Million)
      • 11.3.13.1 Australia: Addiction Therapeutics Market, by Distribution Channel and Revenue and Forecast to 2031 (USD Million)
    • 11.3.14 Rest of Asia Pacific: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
      • 11.3.14.1 Rest of Asia Pacific: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
    • 11.3.15 Rest of Asia Pacific Addiction Therapeutics Market, by Treatment Typeand Revenue and Forecast to 2031 (USD Million)
    • 11.3.16 Rest of Asia Pacific Addiction Therapeutics Market, by Drug Typeand Revenue and Forecast to 2031 (USD Million)
    • 11.3.17 Rest of Asia Pacific Addiction Therapeutics Market, by Treatment Center and Revenue and Forecast to 2031(USD Million)
      • 11.3.17.1 Rest of Asia Pacific: Addiction Therapeutics Market, by Distribution Channel and Revenue and Forecast to 2031 (USD Million)
  • 11.4 Middle East and Africa: Addiction Therapeutics Market
    • 11.4.1 Overview
    • 11.4.2 Middle East and Africa: Addiction Therapeutics Market - Revenue and Forecast to 2031 (US$ Million)
    • 11.4.3 Middle East and Africa Addiction Therapeutics Market, by Treatment Typeand Revenue and Forecast to 2031 (USD Million)
    • 11.4.4 Middle East and Africa Addiction Therapeutics Market, by Drug Typeand Revenue and Forecast to 2031 (USD Million)
    • 11.4.5 Middle East and Africa Addiction Therapeutics Market, by Treatment Center and Revenue and Forecast to 2031(USD Million)
      • 11.4.5.1 Middle East and Africa: Addiction Therapeutics Market, by Distribution Channel and Revenue and Forecast to 2031 (USD Million)
    • 11.4.6 Middle East and Africa: Addiction Therapeutics Market, by Country, 2024 and 2031 (%)
    • 11.4.7 Saudi Arabia: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
      • 11.4.7.1 Saudi Arabia: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
      • 11.4.7.2 Saudi Arabia Addiction Therapeutics Market, by Treatment Typeand Revenue and Forecast to 2031 (USD Million)
      • 11.4.7.3 Saudi Arabia Addiction Therapeutics Market, by Drug Typeand Revenue and Forecast to 2031 (USD Million)
      • 11.4.7.4 Saudi Arabia Addiction Therapeutics Market, by Treatment Center and Revenue and Forecast to 2031(USD Million)
      • 11.4.7.5 Saudi Arabia: Addiction Therapeutics Market, by Distribution Channel and Revenue and Forecast to 2031 (USD Million)
    • 11.4.8 UAE: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
      • 11.4.8.1 UAE: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
      • 11.4.8.2 UAE Addiction Therapeutics Market, by Treatment Typeand Revenue and Forecast to 2031 (USD Million)
      • 11.4.8.3 UAE Addiction Therapeutics Market, by Drug Typeand Revenue and Forecast to 2031 (USD Million)
      • 11.4.8.4 UAE Addiction Therapeutics Market, by Treatment Center and Revenue and Forecast to 2031(USD Million)
      • 11.4.8.5 UAE: Addiction Therapeutics Market, by Distribution Channel and Revenue and Forecast to 2031 (USD Million)
    • 11.4.9 South Africa: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
      • 11.4.9.1 South Africa: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
      • 11.4.9.2 South Africa Addiction Therapeutics Market, by Treatment Typeand Revenue and Forecast to 2031 (USD Million)
      • 11.4.9.3 South Africa Addiction Therapeutics Market, by Drug Typeand Revenue and Forecast to 2031 (USD Million)
      • 11.4.9.4 South Africa Addiction Therapeutics Market, by Treatment Center and Revenue and Forecast to 2031(USD Million)
      • 11.4.9.5 South Africa: Addiction Therapeutics Market, by Distribution Channel and Revenue and Forecast to 2031 (USD Million)
    • 11.4.10 Rest of Middle East and Africa: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
      • 11.4.10.1 Rest of Middle East and Africa: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
      • 11.4.10.2 Rest of Middle East and Africa Addiction Therapeutics Market, by Treatment Typeand Revenue and Forecast to 2031 (USD Million)
      • 11.4.10.3 Rest of Middle East and Africa Addiction Therapeutics Market, by Drug Typeand Revenue and Forecast to 2031 (USD Million)
      • 11.4.10.4 Rest of Middle East and Africa Addiction Therapeutics Market, by Treatment Center and Revenue and Forecast to 2031(USD Million)
      • 11.4.10.5 Rest of Middle East and Africa: Addiction Therapeutics Market, by Distribution Channel and Revenue and Forecast to 2031 (USD Million)
  • 11.5 South and Central America: Addiction Therapeutics Market
    • 11.5.1 Overview
    • 11.5.2 South and Central America: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
    • 11.5.3 South and Central America Addiction Therapeutics Market, by Treatment Typeand Revenue and Forecast to 2031 (USD Million)
    • 11.5.4 South and Central America Addiction Therapeutics Market, by Drug Typeand Revenue and Forecast to 2031 (USD Million)
    • 11.5.5 South and Central America Addiction Therapeutics Market, by Treatment Center and Revenue and Forecast to 2031(USD Million)
      • 11.5.5.1 South and Central America: Addiction Therapeutics Market, by Distribution Channel and Revenue and Forecast to 2031 (USD Million)
    • 11.5.6 South and Central America: Addiction Therapeutics Market, by Country, 2024 and 2031 (%)
    • 11.5.7 Brazil: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
      • 11.5.7.1 Brazil: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
      • 11.5.7.2 Brazil Addiction Therapeutics Market, by Treatment Typeand Revenue and Forecast to 2031 (USD Million)
      • 11.5.7.3 Brazil Addiction Therapeutics Market, by Drug Typeand Revenue and Forecast to 2031 (USD Million)
      • 11.5.7.4 Brazil Addiction Therapeutics Market, by Treatment Center and Revenue and Forecast to 2031(USD Million)
      • 11.5.7.5 Brazil: Addiction Therapeutics Market, by Distribution Channel and Revenue and Forecast to 2031 (USD Million)
    • 11.5.8 Argentina: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
      • 11.5.8.1 Argentina: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
      • 11.5.8.2 Argentina Addiction Therapeutics Market, by Treatment Typeand Revenue and Forecast to 2031 (USD Million)
      • 11.5.8.3 Argentina Addiction Therapeutics Market, by Drug Typeand Revenue and Forecast to 2031 (USD Million)
      • 11.5.8.4 Argentina Addiction Therapeutics Market, by Drug Type and Revenue and Forecast to 2031(USD Million)
      • 11.5.8.5 Argentina: Addiction Therapeutics Market, by Distribution Channel and Revenue and Forecast to 2031 (USD Million)
    • 11.5.9 Rest of South and Central America: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
      • 11.5.9.1 Rest of South and Central America: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
      • 11.5.9.2 Rest of South and Central America Addiction Therapeutics Market, by Treatment Typeand Revenue and Forecast to 2031 (USD Million)
      • 11.5.9.3 Rest of South and Central America Addiction Therapeutics Market, by Drug Typeand Revenue and Forecast to 2031 (USD Million)
      • 11.5.9.4 Rest of South and Central America Addiction Therapeutics Market, by Treatment Center and Revenue and Forecast to 2031(USD Million)
      • 11.5.9.5 Rest of South and Central America Addiction Therapeutics Market, by Distribution Channel and Revenue and Forecast to 2031(USD Million)

12. Impact of COVID-19 Pandemic on Global Addiction Therapeutics Market

  • 12.1 North America: Impact Assessment of COVID-19 Pandemic
  • 12.2 Europe: Impact Assessment Of COVID-19 Pandemic
  • 12.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
  • 12.4 Rest of the World: Impact Assessment of COVID-19 Pandemic

13. Addictions Therapeutics Market and Industry Landscape

  • 13.1 Overview
  • 13.2 Growth Strategies Done by the Companies in the Market, (%)
  • 13.3 Organic Developments
    • 13.3.1 Overview
  • 13.4 Inorganic Developments
    • 13.4.1 Overview

14. Company Profiles

  • 14.1 Indivior PLC
    • 14.1.1 Key Facts
    • 14.1.2 Business Description
    • 14.1.3 Products and Services
    • 14.1.4 Financial Overview
    • 14.1.5 SWOT Analysis
    • 14.1.6 Key Developments
  • 14.2 Pfizer Inc.
    • 14.2.1 Key Facts
    • 14.2.2 Business Description
    • 14.2.3 Products and Services
    • 14.2.4 Financial Overview
    • 14.2.5 SWOT Analysis
    • 14.2.6 Key Developments
  • 14.3 GlaxoSmithKline plc.
    • 14.3.1 Key Facts
    • 14.3.2 Business Description
    • 14.3.3 Products and Services
    • 14.3.4 Financial Overview
    • 14.3.5 SWOT Analysis
    • 14.3.6 Key Developments
  • 14.4 Bausch Health Companies Inc.
    • 14.4.1 Key Facts
    • 14.4.2 Business Description
    • 14.4.3 Products and Services
    • 14.4.4 Financial Overview
    • 14.4.5 SWOT Analysis
    • 14.4.6 Key Developments
  • 14.5 Cipla Inc.
    • 14.5.1 Key Facts
    • 14.5.2 Business Description
    • 14.5.3 Products and Services
    • 14.5.4 Financial Overview
    • 14.5.5 SWOT Analysis
    • 14.5.6 Key Developments
  • 14.6 Orexo AB
    • 14.6.1 Key Facts
    • 14.6.2 Business Description
    • 14.6.3 Products and Services
    • 14.6.4 Financial Overview
    • 14.6.5 SWOT Analysis
    • 14.6.6 Key Developments
  • 14.7 Purdue Pharma L.P.
    • 14.7.1 Key Facts
    • 14.7.2 Business Description
    • 14.7.3 Products and Services
    • 14.7.4 Financial Overview
    • 14.7.5 SWOT Analysis
    • 14.7.6 Key Developments
  • 14.8 Alvogen
    • 14.8.1 Key Facts
    • 14.8.2 Business Description
    • 14.8.3 Products and Services
    • 14.8.4 Financial Overview
    • 14.8.5 SWOT Analysis
    • 14.8.6 Key Developments
  • 14.9 Camurus AB
    • 14.9.1 Key Facts
    • 14.9.2 Business Description
    • 14.9.3 Products and Services
    • 14.9.4 Financial Overview
    • 14.9.5 SWOT Analysis
    • 14.9.6 Key Developments
  • 14.10 Hikma Pharmaceuticals PLC
    • 14.10.1 Key Facts
    • 14.10.2 Business Description
    • 14.10.3 Products and Services
    • 14.10.4 Financial Overview
    • 14.10.5 SWOT Analysis
    • 14.10.6 Key Developments

15. Appendix

  • 15.1 About The Insight Partners
  • 15.2 Glossary of Terms